
Please try another search
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company’s marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease who require additional lowering of LDL-C. Its products also include NILEMDO, an ATP Citrate Lyase (ACL) inhibitor that lowers LDL-C and cardiovascular risk by reducing cholesterol biosynthesis and up-regulating the LDL receptors; and NUSTENDI, a bempedoic acid and ezetimibe tablet to treat elevated LDL-C. It has license and collaboration agreements with Daiichi Sankyo Co. Ltd to; Otsuka Pharmaceutical Co., Ltd; and Daiichi Sankyo Europe GmbH. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.
Name | Age | Since | Title |
---|---|---|---|
Daniel S. Janney | 56 | 2012 | Independent Director |
Sheldon L. Koenig | 56 | 2020 | President, CEO & Director |
J. Martin Carroll | 74 | 2022 | Independent Chairperson |
Jay P. Shepard | 65 | 2018 | Independent Director |
Karin Bornfeldt | - | 2022 | Member of Scientific Advisory Board |
Gerald I. Shulman | - | 2022 | Member of Scientific Advisory Board |
R. Preston Mason | - | 2022 | Member of Scientific Advisory Board |
Gabrielle Fredman | - | 2022 | Member of Scientific Advisory Board |
Erin A. Bohula | - | 2022 | Member of Scientific Advisory Board |
Peter Libby | 78 | 2022 | Member of Scientific Advisory Board |
Pradeep Natarajan | - | 2022 | Member of Scientific Advisory Board |
Jeffrey Bender | - | 2022 | Member of Scientific Advisory Board |
Stephen Charles Rocamboli | 53 | 2022 | Independent Director |
David E. Cohen | - | 2022 | Member of Scientific Advisory Board |
Dennis Bruemmer | - | 2022 | Member of Scientific Advisory Board |
Marilyn Glassberg | - | 2022 | Member of Scientific Advisory Board |
John Craig Thompson | - | 2025 | Independent Director |
Seth H. Z. Fischer | 69 | 2021 | Independent Director |
Tracy M. Woody | 55 | 2019 | Independent Director |
Robert E. Hoffman | 59 | 2025 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review